Atrium Therapeutics, Inc.

Atrium Therapeutics, Inc.

RNA
Atrium Therapeutics, Inc.US flagNASDAQ Global Select
12.17
USD
-0.08
- -
208.18MMarket Cap

Income Statement (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
2
7
9
9
10
11
19
+ Sales & Services Revenue
- -
2
7
9
9
10
11
19
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
-2
-7
-9
-9
-10
-11
-19
- Operating Expenses
11
20
51
127
188
16
24
95
+ Selling, General & Admin
2
5
13
26
38
3
5
42
+ Research & Development
8
15
38
101
150
13
19
54
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-10
-17
-44
-118
-179
-6
-13
-77
- Non-Operating (Income) Loss
1
7
- -
- -
-5
- -
- -
- -
+ Interest Expense, Net
1
7
- -
- -
-5
-24
-57
- -
+ Interest Expense
1
7
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
5
24
57
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
24
57
- -
Pretax Income
-11
-25
-44
-118
-174
-6
-13
-77
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
12
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-11
-25
-44
-118
-174
-6
-25
-77
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-11
-25
-44
-118
-174
-6
-25
-77
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-11
-25
-44
-118
-174
-6
-25
-77
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-11
-25
-44
-118
-174
-6
-25
-77
EBIT
-10
-17
-44
-118
-179
-6
-13
-77
EBITDA
-10
-17
-44
-117
-178
-6
-13
-76
EBITDA Margin (%)
-2,668.87
-732.38
-646.88
-1,258.97
-1,924.61
-63.99
-119.72
-410.84
EBITA
-10
-17
-44
-118
-179
-6
-13
-77
Gross Margin (%)
100
100
100
100
100
100
100
100
Operating Margin (%)
-2,769.92
-747.39
-652.38
-1,265.83
-1,939.65
-65.4
-121.3
-412.58
Profit Margin (%)
-2,959.37
-1,066.58
-653.53
-1,265.38
-1,886.33
-65.39
-230.54
-411.88
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
0.01
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
1
- -
- -
- -
Basic Weighted Avg Shares
21
21
22
21
52
17
17
17
Basic EPS, GAAP
-0.54
-1.2
-2.05
-5.7
-3.34
-0.37
-1.47
-4.48
Basic EPS from Cont Ops
-0.54
-1.2
-2.05
-5.7
-3.34
-0.37
-1.47
-4.48
Diluted Weighted Avg Shares
21
21
22
21
52
17
17
17
Diluted EPS, GAAP
-0.54
-1.2
-2.05
-5.7
-3.34
-0.37
-1.47
-4.48
Diluted EPS from Cont Ops
-0.54
-1.2
-2.05
-5.7
-3.34
-0.37
-1.47
-4.48

Balance Sheet (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
3
96
332
411
623
1
- -
273
+ Cash, Cash Equivalents & STI
3
95
328
406
611
410
1,282
270
+ Cash & Cash Equivalents
3
95
321
320
340
- -
- -
270
+ ST Investments
- -
- -
7
85
270
410
1,282
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
4
1
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
2
1
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
2
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
4
6
8
-410
-1,281
3
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
1
2
16
16
9
7
6
+ Property, Plant & Equip, Net
1
1
2
16
15
9
7
6
+ Property, Plant & Equip
2
2
4
17
18
10
8
8
- Accumulated Depreciation
1
2
2
2
3
1
1
3
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
1
- -
1
1
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
1
- -
1
1
- -
- -
- -
Total Assets
4
97
334
428
639
10
7
278
+ Payables & Accruals
2
2
8
14
33
1
2
13
+ Accounts Payable
2
2
- -
3
5
- -
1
4
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
8
11
28
1
1
9
+ ST Debt
3
3
- -
2
3
4
4
4
+ ST Borrowings
3
3
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
2
3
4
4
4
+ Other ST Liabilities
- -
5
7
14
16
29
21
25
+ Deferred Revenue
- -
4
4
5
5
28
21
22
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
3
9
11
1
- -
3
Total Current Liabilities
5
10
15
30
52
34
27
42
+ LT Debt
8
2
1
10
8
6
3
- -
+ LT Borrowings
8
2
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
1
10
8
6
3
- -
+ Other LT Liabilities
33
150
12
7
1
41
39
29
+ Accrued Liabilities
- -
15
12
7
1
41
38
29
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
33
135
- -
- -
- -
- -
1
1
Total Noncurrent Liabilities
40
152
13
16
9
47
41
29
Total Liabilities
45
162
28
46
61
81
68
71
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
-43
373
566
939
- -
- -
207
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
-43
373
566
939
- -
- -
207
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-42
-22
-67
-185
-359
- -
- -
- -
+ Other Equity
- -
- -
- -
- -
-3
- -
3
- -
Equity Before Minority Interest
-41
-65
306
381
578
-71
-61
207
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-41
-65
306
381
578
-71
-61
207
Total Liabilities & Equity
4
97
334
428
639
10
7
278
Shares Outstanding
31
31
38
48
70
17
17
17
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
1
12
11
10
7
4
Net Debt
7
-90
-321
-320
-340
- -
- -
-270
Net Debt to Equity
-17.59
137.76
-104.98
-84.01
-58.88
- -
- -
-130.25
Tangible Common Equity Ratio
-1,032.87
-67.44
91.71
89.21
90.49
-686.09
-850.38
74.47
Current Ratio
0.7
9.35
22.74
13.86
12
0.03
0.02
6.53
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-11
-25
-44
-118
-174
-6
-25
-50
+ Depreciation & Amortization
- -
- -
- -
1
1
- -
- -
- -
+ Non-Cash Items
1
8
5
18
29
3
15
8
+ Stock-Based Compensation
- -
- -
4
17
27
3
3
8
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
12
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
7
- -
1
2
- -
- -
1
+ Chg in Non-Cash Work Cap
1
19
2
5
7
60
-13
- -
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
1
1
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-2
-3
-7
- -
- -
-1
+ Inc (Dec) in Accts Payable
1
1
8
12
21
-1
- -
14
+ Inc (Dec) in Other
- -
19
-3
-5
-7
59
-13
-13
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-10
2
-37
-95
-136
56
-23
-41
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
-4
-3
- -
- -
-1
+ Acq of Fixed Prod Assets
- -
- -
-1
-4
-3
- -
- -
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
274
175
345
92
1,001
- -
+ Increase in Capital Stock
- -
- -
274
175
345
92
1,001
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-7
-79
-187
-126
-847
- -
+ Dec in LT Investment
- -
- -
- -
7
169
335
586
- -
+ Inc in LT Investment
- -
- -
-7
-85
-356
-461
-1,434
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
126
847
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-8
-83
-190
- -
- -
-1
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
5
17
-5
- -
- -
- -
- -
- -
+ Cash From Debt
5
19
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
-3
-5
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
73
3
2
1
-148
-978
43
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
5
89
272
176
346
-56
23
43
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-5
91
227
-1
20
- -
- -
- -
EBITDA
-10
-17
-44
-117
-178
-6
-13
-76
EBITDA Margin (%)
-2,668.87
-732.38
-646.88
-1,258.97
-1,924.61
-63.99
-119.72
-410.84
Free Cash Flow
-10
2
-38
-99
-139
56
-23
-43
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
19
-43
-99
-139
56
-23
-43
Free Cash Flow per Basic Share
-0.47
0.11
-1.76
-4.76
-2.67
3.28
-1.33
-2.49
Price/Free Cash Flow
- -
- -
-15.35
-5.41
-8.67
2.73
-22.34
-31.09
Cash Flow to Net Income
0.86
-0.1
0.84
0.8
0.78
-8.83
0.9
0.54
Capital Expenditures
- -
- -
-1
-4
-3
- -
- -
-1